+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levodopa"

From
From
Carbidopa & Levodopa Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Carbidopa & Levodopa Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 191 Pages
  • Global
From
Levodopa Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Levodopa Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Levodopa Market - Global Strategic Business Report - Product Thumbnail Image

Levodopa Market - Global Strategic Business Report

  • Report
  • January 2026
  • 377 Pages
  • Global
From
Anti-Parkinson's Drugs: Global Markets to 2030 - Product Thumbnail Image

Anti-Parkinson's Drugs: Global Markets to 2030

  • Report
  • July 2025
  • 134 Pages
  • Global
From
Dyskinesia Market - Global Forecast 2025-2032 - Product Thumbnail Image

Dyskinesia Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 194 Pages
  • Global
From
Benserazide Hydrochloride Market - Global Forecast 2025-2032 - Product Thumbnail Image

Benserazide Hydrochloride Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 194 Pages
  • Global
From
From
From
Entacapone Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Entacapone Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 190 Pages
  • Global
From
Tolcapone Tablets Market - Global Forecast 2025-2030 - Product Thumbnail Image

Tolcapone Tablets Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Entacapone API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Entacapone API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 189 Pages
  • Global
From
From
From
From
Parkinson's Disease Drugs - Global Strategic Business Report - Product Thumbnail Image

Parkinson's Disease Drugs - Global Strategic Business Report

  • Report
  • January 2026
  • 382 Pages
  • Global
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 506 Pages
  • Global
From
Loading Indicator

Levodopa is a drug used to treat Parkinson's disease, a neurological disorder that affects movement. It is a dopamine precursor, meaning it is converted into dopamine in the brain, which helps to reduce the symptoms of Parkinson's. Levodopa is usually taken in combination with other drugs, such as carbidopa, to increase its effectiveness. It is one of the most commonly prescribed drugs for Parkinson's, and is often the first line of treatment. Levodopa is a part of the larger Central Nervous System (CNS) drug market, which includes drugs used to treat a variety of neurological disorders. The CNS drug market is highly competitive, with many different companies offering various treatments. Some of the companies in the Levodopa market include Merck, Novartis, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more